This 2021 study evaluated the long-term efficacy of adjuvant ozone therapy (O₃T) in managing chronic pelvic pain in cancer survivors. Six patients with refractory pelvic pain, unresponsive to standard treatments, received O₃T via rectal insufflation. Pain levels, assessed using the Visual Analog Scale (VAS), showed significant reductions: continuous pelvic pain